Innate Lymphoid Cells Are the Rheostat of Immune Response in the Kidney

Area of Science:

• Immunology
• Nephrology

Background:

• Kidney disease is a leading global cause of mortality.
• Innate lymphoid cells (ILCs) are crucial immune cells involved in various physiological and pathological processes.
• Recent research highlights the significant role of ILCs in the context of kidney diseases.

Purpose of the Study:

• To review the multifaceted roles of ILC subsets, specifically ILC1s, ILC2s, and ILC3s, in the pathogenesis and progression of kidney diseases.
• To elucidate the mechanisms by which ILCs influence kidney health and disease, including cytokine production and interaction with renal cells.
• To identify potential therapeutic targets within ILC populations for kidney disease management.

Main Methods:

• Literature review and synthesis of existing research on ILCs in kidney diseases.
• Analysis of ILC classification, distribution, and function within the kidney.
• Examination of the specific contributions of ILC1, ILC2, and ILC3 subsets to conditions like acute kidney injury (AKI) and chronic kidney disease (CKD).

Main Results:

• ILCs are found in renal vessels, and ILC3s contribute to ectopic lymphoid structures.
• ILCs secrete cytokines that modulate renal parenchymal cells and recruit other immune cells.
• ILC2s demonstrate protective effects in AKI and glomerulonephritis.
• ILC3s are implicated in promoting fibrosis in CKD, while ILC2 roles in kidney fibrosis are debated.
• ILC1s and ILC3s are associated with promoting glomerulonephritis.

Conclusions:

• ILCs play complex and often opposing roles in various kidney diseases.
• ILC subsets exhibit distinct functions in acute versus chronic kidney conditions.
• Further research into ILC modulation, plasticity, and interactions is essential for developing novel kidney disease therapies.